# Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia

> **NCT06896994** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Postherpetic Neuralgia

## Interventions

- **DRUG:** esketamine group
- **DRUG:** control group

## Key facts

- **NCT ID:** NCT06896994
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06896994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06896994, "Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT06896994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*